Life sciences M&A comes with unique challenges that require thoughtful and creative structuring. Bridging valuation gaps between buyers...

Various biotech companies have completed or launched their IPOs so far in 2025. As of early February, five sizeable life sciences...

On February 3, 2025, the U.S. District Court for the Central District of California granted a motion to dismiss filed by the California...

The U.S. Department of Treasury (Treasury) recently released proposed regulations under §§ 959 and 961 and related Code sections...

As in-scope companies prepare to begin publishing climate disclosures in California in 2026 (assuming these laws survive the ongoing...